Tamar Liron

2.3k total citations
31 papers, 1.9k citations indexed

About

Tamar Liron is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tamar Liron has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tamar Liron's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Bone health and treatments (5 papers) and Erythropoietin and Anemia Treatment (5 papers). Tamar Liron is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Bone health and treatments (5 papers) and Erythropoietin and Anemia Treatment (5 papers). Tamar Liron collaborates with scholars based in Israel, United States and Germany. Tamar Liron's co-authors include Daria Mochly‐Rosen, Gerald W. Dorn, Che-Hong Chen, Yankel Gabet, Guangyu Wu, John N. Lorenz, Gabriela Constantin, Eugene C. Butcher, Carlo Laudanna and Harvey S. Hahn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Tamar Liron

30 papers receiving 1.9k citations

Peers

Tamar Liron
Chantal Allamargot United States
Christina A. Pacak United States
Athanasios Didangelos United Kingdom
Nicholas A. Lanson United States
Leslie Bridges United Kingdom
Hind Lal United States
Chantal Allamargot United States
Tamar Liron
Citations per year, relative to Tamar Liron Tamar Liron (= 1×) peers Chantal Allamargot

Countries citing papers authored by Tamar Liron

Since Specialization
Citations

This map shows the geographic impact of Tamar Liron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Liron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Liron more than expected).

Fields of papers citing papers by Tamar Liron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Liron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Liron. The network helps show where Tamar Liron may publish in the future.

Co-authorship network of co-authors of Tamar Liron

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Liron. A scholar is included among the top collaborators of Tamar Liron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Liron. Tamar Liron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liron, Tamar, et al.. (2023). The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer. International Journal of Molecular Sciences. 24(9). 7773–7773. 3 indexed citations
3.
Liron, Tamar, et al.. (2023). The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans. International Journal of Molecular Sciences. 24(4). 4060–4060. 7 indexed citations
4.
Meger, Michelle Nascimento, Tamar Liron, Sahar Hiram‐Bab, et al.. (2021). Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis. Frontiers in Pharmacology. 12. 638128–638128. 10 indexed citations
5.
Ben‐Califa, Nathalie, Sahar Hiram‐Bab, Tamar Liron, et al.. (2020). Erythropoietin receptor in B cells plays a role in bone remodeling in mice. Theranostics. 10(19). 8744–8756. 19 indexed citations
7.
Ben‐Califa, Nathalie, Maria Ibrahim, Tamar Liron, et al.. (2020). Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice. Frontiers in Immunology. 11. 561294–561294. 7 indexed citations
8.
Meger, Michelle Nascimento, Sahar Hiram‐Bab, Tamar Liron, et al.. (2018). Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis. Frontiers in Immunology. 9. 2963–2963. 112 indexed citations
9.
Bell, Rachel E., Tamar Golan, Danna Sheinboim, et al.. (2016). Enhancer methylation dynamics contribute to cancer plasticity and patient mortality. Genome Research. 26(5). 601–611. 84 indexed citations
10.
Liron, Tamar, et al.. (2007). Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels. Neuroscience. 146(1). 152–159. 10 indexed citations
11.
Liron, Tamar, et al.. (2007). Rational design of a selective antagonist of ε protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide. Journal of Molecular and Cellular Cardiology. 42(4). 835–841. 15 indexed citations
12.
Shumilla, Jennifer A., Tamar Liron, Daria Mochly‐Rosen, Joan J. Kendig, & Sarah M. Sweitzer. (2005). Ethanol Withdrawal–Associated Allodynia and Hyperalgesia: Age-Dependent Regulation by Protein Kinase Cϵ and γ Ιsozymes. Journal of Pain. 6(8). 535–549. 34 indexed citations
13.
Begley, Rebecca, Tamar Liron, Jeremy L. Baryza, & Daria Mochly‐Rosen. (2004). Biodistribution of intracellularly acting peptides conjugated reversibly to Tat. Biochemical and Biophysical Research Communications. 318(4). 949–954. 72 indexed citations
14.
Knauf, Jeffrey A., Laura Sterian Ward, Yuri E. Nikiforov, et al.. (2002). Isozyme-Specific Abnormalities of PKC in Thyroid Cancer: Evidence for Post-Transcriptional Changes in PKC Epsilon. The Journal of Clinical Endocrinology & Metabolism. 87(5). 2150–2159. 30 indexed citations
15.
Chaudary, Naz, et al.. (2002). Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochemistry and Cell Biology. 80(5). 655–665. 28 indexed citations
16.
Mochly‐Rosen, Daria, James A. Fagin, Jeffrey A. Knauf, et al.. (2001). Spontaneous occurrence of an inhibitor of protein kinase C localization in a thyroid cancer cell line: role in thyroid tumorigenesis. Advances in Enzyme Regulation. 41(1). 87–97. 2 indexed citations
17.
Chen, Leon, Harvey S. Hahn, Guangyu Wu, et al.. (2001). Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC. Proceedings of the National Academy of Sciences. 98(20). 11114–11119. 454 indexed citations
18.
Dorn, Gerald W., Miriam C. Souroujon, Tamar Liron, et al.. (1999). Sustained in vivo cardiac protection by a rationally designed peptide that causes ɛ protein kinase C translocation. Proceedings of the National Academy of Sciences. 96(22). 12798–12803. 313 indexed citations
19.
Knauf, Jeffrey A., Rossella Elisei, Daria Mochly‐Rosen, et al.. (1999). Involvement of Protein Kinase Cε (PKCε) in Thyroid Cell Death. Journal of Biological Chemistry. 274(33). 23414–23425. 65 indexed citations
20.
Laudanna, Carlo, Daria Mochly‐Rosen, Gabriela Constantin, Eugene C. Butcher, & Tamar Liron. (1998). Evidence of ζ Protein Kinase C Involvement in Polymorphonuclear Neutrophil Integrin-dependent Adhesion and Chemotaxis. Journal of Biological Chemistry. 273(46). 30306–30315. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026